Myriad Genetics

Myriad Genetics, Inc. is a prominent American company based in Salt Lake City, Utah, specializing in molecular diagnostics and precision medicine. Founded in 1991, it focuses on genetic testing and personalized healthcare solutions to assess disease risk, guide treatment decisions, and enhance patient outcomes. The company reported $690.6 million in revenue in 2021 and employs around 2,600 people globally. Myriad offers a range of services, including predictive medicine for hereditary cancers, precision medicine to determine drug response, and reproductive health solutions through carrier screening and prenatal testing. The company also provides clinical trial support and biomarker discovery for pharmaceutical development. Myriad collaborates with healthcare providers, patients, and pharmaceutical companies to deliver its testing services and support informed treatment decisions. The company is committed to educating patients and clinicians about genetic literacy and disease prevention.